Pharsight

JANSSEN BIOTECH INC patents facing oppositions

Top patents of JANSSEN BIOTECH INC facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3827845B1 30 Mar, 2022 Subcutaneous formulations of anti-cd38 antibodies and their uses Nov, 2036 5
EP3370770B1 20 Jan, 2021 Subcutaneous formulations of anti-cd38 antibodies and their uses Nov, 2036 3
EP3883606B9 04 Oct, 2023 Safe and effective method of treating ulcerative colitis with anti-il12/il23 antibody Sep, 2039 2
EP3219328B1 17 Jun, 2020 Human anti-il-23 antibodies, compositions, method and uses Dec, 2026 2
EP2569419B1 20 Mar, 2019 Differentiation of human embryonic stem cells May, 2031 1